On March 22, 2019, in follow-up to a delay by the World Health Organization (WHO) in recommending H3N2 strain for inclusion in the 2019-2020 seasonal influenza vaccines, the Center for Biologics Evaluation and Research reconvened the VRBPAC to discuss and make recommendations specifically on the H3N2 strain. The VRBPAC previously met on March 6, 2019, and made recommendations on the selection of all other strains to be included in seasonal influenza virus vaccines for the 2019-2020 influenza season. The committee unainimously agreed (10 of 10 members) with the WHO’s recommendation.
Back to All Events
Earlier Event: March 22Advisory Committee on Heritable Disorders in Newborns and Children
Later Event: March 27Cancelled: Pulmonary-Allergy Drugs Advisory Committee